BioMarin Pharmaceutical

ISIN US09061G1013

WKN 924801

Market cap (in EUR)

9,975 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Chart

Financials

Key metrics

Market capitalisation, EUR	9,975 m
EPS, EUR	2.42
P/B ratio	1.9
P/E ratio	22.9
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	2,625 m
Net income, EUR	395 m
Profit margin	15.03%

What ETF is BioMarin Pharmaceutical in?

There are 32 ETFs which contain BioMarin Pharmaceutical. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioMarin Pharmaceutical is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc	0.02%	Equity World	5,308
iShares MSCI World UCITS ETF (Dist)	0.01%	Equity World	7,356
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating	0.02%	Equity World Multi-Asset Strategy	864
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist)	0.04%	Equity World Health Care Social/Environmental	465
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing	0.01%	Equity World Multi-Asset Strategy	14
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating	0.01%	Equity World Multi-Asset Strategy	662
JPMorgan Global Equity Premium Income Active UCITS ETF USD (acc)	0.16%	Equity World Covered Call Alternative Investments	72
iShares MSCI USA Islamic UCITS ETF	0.08%	Equity United States Islamic Investing	263
iShares MSCI USA ESG Enhanced CTB UCITS ETF USD (Dist)	0.01%	Equity United States Social/Environmental	13,326
iShares MSCI North America UCITS ETF	0.02%	Equity North America	1,090
iShares MSCI World Islamic UCITS ETF	0.05%	Equity World Islamic Investing	802
UBS Core MSCI World UCITS ETF USD dis	0.02%	Equity World	1,287
iShares MSCI World Screened UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental	943
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental Climate Change	133
JPMorgan BetaBuilders US Equity UCITS ETF (Dist)	0.02%	Equity United States	2
UBS Core MSCI World UCITS ETF hGBP dis	0.02%	Equity World	92
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing	0.01%	Equity World Multi-Asset Strategy	34
UBS Core MSCI USA UCITS ETF USD dis	0.02%	Equity United States	1,178
iShares MSCI ACWI UCITS ETF USD (Acc)	0.01%	Equity World	21,254
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist	0.01%	Equity North America Social/Environmental Climate Change	43
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing	0.02%	Equity World Multi-Asset Strategy	64
JPMorgan Global Equity Premium Income Active UCITS ETF USD (dist)	0.16%	Equity World Covered Call Alternative Investments	1,127
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating	0.01%	Equity World Multi-Asset Strategy	186
iShares MSCI USA Screened UCITS ETF USD (Dist)	0.02%	Equity United States Social/Environmental	1,347
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	Equity World Social/Environmental	485
UBS Core MSCI World UCITS ETF hEUR acc	0.02%	Equity World	292
UBS Core MSCI USA UCITS ETF EUR Hedged dis	0.02%	Equity United States	328
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist)	0.00%	Equity World Social/Environmental	957
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.86%	Equity United States Health Care Biotech	44
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.02%	Equity North America Social/Environmental	27
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing	0.01%	Equity World Multi-Asset Strategy	87
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating	0.01%	Equity World Multi-Asset Strategy	85

Performance

Returns overview

YTD	-18.34%
1 month	+9.28%
3 months	+14.67%
6 months	+10.87%
1 year	-18.61%
3 years	-47.14%
5 years	-28.69%
Since inception (MAX)	-38.50%
2024	-27.75%
2023	-8.14%
2022	+20.96%
2021	+12.16%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).